Sanofi-Aventis (France) Asks U.S. Court to Block Sandoz, Inc.'s Generic Blood Thinner

Reuters -- Sanofi-Aventis (SASY.PA) on Monday asked a U.S. court to block the approval of a generic version of its widely used blood clot treatment Lovenox, arguing that federal regulators improperly approved the medicine last week.